Plasma Cell Neoplasm — Trials

Plasma Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,420 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 1,474 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03652064	A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy	completed	Phase 3	395	Janssen Research & Development, LLCINDUSTRY	13	Jun 2, 2026	clinicaltrials
NCT07614243	Long Non-coding RNA (lncRNA) ZFAS1-Mediated Mechanism of Roasted Nux Vomica in Intervening Bortezomib-Induced Peripheral Neuropathy(ZFAS1-BIPN)	completed	N/A	22	The First Affiliated Hospital of Zhejiang Chinese Medical University